Chapter 106. Plasma Cell Disorders (Part 2)

Chia sẻ: Thuoc Thuoc | Ngày: | Loại File: PDF | Số trang:5

Thêm vào BST

Báo xấu

74
lượt xem 5
download

Download Vui lòng tải xuống để xem tài liệu đầy đủ

Representative patterns of serum electrophoresis. The upper panel illustrates the normal pattern of serum protein on electrophoresis. Since there are many different immunoglobulins in the serum, their differing mobilities in an electric field produce a broad peak. In conditions associated with increases in polyclonal immunoglobulin, the broad peak is more prominent (middle panel). In monoclonal gammopathies, the predominance of a product of a single cell produces a "church spire" sharp peak, usually in the γ globulin region (bottom panel). The nature of the M component is variable in plasma cell disorders. It may be an intact antibody molecule of any heavy...

Chủ đề:

Bình luận(0) Đăng nhập để gửi bình luận!

Lưu

Nội dung Text: Chapter 106. Plasma Cell Disorders (Part 2)

Chapter 106. Plasma Cell Disorders (Part 2) Figure 106-1 Representative patterns of serum electrophoresis. The upper panel illustrates the normal pattern of serum protein on electrophoresis. Since there are
many different immunoglobulins in the serum, their differing mobilities in an electric field produce a broad peak. In conditions associated with increases in polyclonal immunoglobulin, the broad peak is more prominent (middle panel). In monoclonal gammopathies, the predominance of a product of a single cell produces a "church spire" sharp peak, usually in the γ globulin region (bottom panel). The nature of the M component is variable in plasma cell disorders. It may be an intact antibody molecule of any heavy chain subclass, or it may be an altered antibody or fragment. Isolated light or heavy chains may be produced. In some plasma cell tumors such as extramedullary or solitary bone plasmacytomas,
used interchangeably. The tumor, its products, and the host response to it result in a number of organ dysfunctions and symptoms of bone pain or fracture, renal failure, susceptibility to infection, anemia, hypercalcemia, and occasionally clotting abnormalities, neurologic symptoms, and manifestations of hyperviscosity. Etiology The cause of myeloma is not known. Myeloma occurred with increased frequency in those exposed to the radiation of nuclear warheads in World War II after a 20-year latency. A variety of chromosomal alterations have been found in patients with myeloma; 13q14 deletions, 17p13 deletions, and 11q abnormalities predominate. The most common translocations are t(11;14)(q13;q32) and t(4;14)(p16;q32), and evidence is strong that errors in switch recombination—the genetic mechanism to change antibody heavy chain isotype—participate in the transformation pathway. Overexpression of myc or ras genes has been noted in some cases. Mutations in p53 and Rb-1 have also been described, but no common molecular pathogenesis has yet emerged. Myeloma has been seen more commonly than expected among farmers, wood workers, leather workers, and those exposed to petroleum products. The neoplastic event in myeloma may involve cells earlier in B cell differentiation than the plasma cell. Circulating B cells bearing surface immunoglobulin that share the
idiotype of the M component are present in myeloma patients. Interleukin (IL) 6 may play a role in driving myeloma cell proliferation; a large fraction of myeloma cells exposed to IL-6 in vitro respond by proliferating. The IL-6 dependency of myeloma is controversial. It remains difficult to distinguish benign from malignant plasma cells on the basis of morphologic criteria in all but a few cases (Fig. 106- 2). Figure 106-2 Multiple myeloma (marrow). The cells bear characteristic morphologic features of plasma cells, round or oval cells with an eccentric nucleus composed of coarsely clumped chromatin, a densely basophilic cytoplasm, and a perinuclear
clear zone (hof) containing the Golgi apparatus. Binucleate and multinucleate malignant plasma cells can be seen.